Gabapentin for Chronic Cough
Gabapentin is an effective treatment option for unexplained chronic cough (cough persisting >8 weeks despite appropriate investigation and treatment), with demonstrated improvements in quality of life, but should only be used after ruling out treatable causes and requires careful discussion of side effects with reassessment at 6 months. 1
When to Use Gabapentin
The 2016 CHEST guidelines provide clear criteria for gabapentin use 1:
- Define unexplained chronic cough first: Cough lasting >8 weeks that remains unexplained after investigation and supervised therapeutic trials according to best-practice guidelines
- Complete proper workup: Patients must undergo objective testing for bronchial hyperresponsiveness and eosinophilic bronchitis, or a therapeutic corticosteroid trial
- Rule out specific causes: Do NOT use inhaled corticosteroids if tests for bronchial hyperresponsiveness and eosinophilia are negative 1
Evidence for Efficacy
Gabapentin has robust support for treating refractory chronic cough:
- Quality of life improvement: A landmark RCT showed gabapentin significantly improved cough-specific quality of life (Leicester Cough Questionnaire score difference of 1.80, p=0.004) with a number needed to treat of 3.58 2
- Cough frequency reduction: Meta-analysis demonstrated reduction in 24-hour cough frequency (mean difference -7.91) 3
- Mechanism: Works through neuromodulation of enhanced neural sensitization, a key component of unexplained cough 1
The evidence shows gabapentin is more effective than placebo and demonstrates the most substantial improvements among neuromodulators studied 3.
Dosing Protocol
Start low and titrate up 1:
- Begin at 300 mg once daily
- Add additional doses each day as tolerated
- Maximum tolerable dose: 1,800 mg daily in two divided doses
- Optimal treatment duration: 12 weeks for maximal effect 3
Side Effects and Monitoring
Common adverse effects (occurred in 31% of patients) 1:
- Confusion, dizziness, dry mouth, fatigue, nausea
- Less common: blurred vision, headache, memory loss
Critical safety considerations 4:
- Discuss risk-benefit profile before initiating treatment
- Mandatory reassessment at 6 months before continuing 1
- Monitor for suicidal thoughts (occurs in ~1 in 500 patients on antiepileptic drugs)
- Can be removed by hemodialysis if needed in overdose
Treatment Algorithm
Step 1: Confirm chronic cough (>8 weeks duration)
Step 2: Complete diagnostic workup:
- Test for bronchial hyperresponsiveness
- Check for eosinophilic bronchitis (sputum eosinophils, exhaled nitric oxide)
- Rule out GERD with appropriate testing
Step 3: Try first-line treatments based on identified causes
Step 4: If cough persists (now "unexplained chronic cough"):
- Consider multimodality speech pathology therapy first 1
- Initiate gabapentin with informed consent about side effects
- Titrate from 300 mg daily to maximum 1,800 mg daily in divided doses
Step 5: Reassess at 6 months:
- If successful: wean to lowest cough-controlling dose (68.3% of practitioners) or taper off completely (24.4%) 5
- If unsuccessful: consider switching to another neuromodulator (amitriptyline) or superior laryngeal nerve block 5
- If cough recurs after successful treatment: reinitiate the same dose that previously worked 5
Important Caveats
Do NOT use gabapentin if:
- Bronchial hyperresponsiveness or eosinophilia testing is positive (use inhaled corticosteroids instead) 1
- Patient has not completed appropriate diagnostic workup
- GERD workup is negative (don't add proton pump inhibitors) 1
Practical considerations:
- Gabapentin is preferred over morphine (which failed to gain guideline approval due to safety concerns) 1
- Among laryngologists, gabapentin (45.1%) and amitriptyline (39.0%) are the preferred first-line neuromodulators 5
- Patients with vocal fold motion asymmetry on videostroboscopy have higher odds of responding to gabapentin (94% vs 56%) 6
The CHEST Expert Panel emphasizes that because health-related quality of life can be severely impacted by unexplained chronic cough, the potential benefits of gabapentin outweigh the side effects in appropriately selected patients 1.